A healthcare PR firm earns coverage for hospitals, health systems, pharmaceutical companies, medical device makers and health technology vendors. The work is standard media relations wrapped in two constraints other categories do not have: regulated claims and patient privacy. Those constraints slow everything down, and the firms that perform in healthcare are the ones that design the programme around the approval cycle rather than complaining about it.
What makes healthcare PR different
Every clinical claim needs substantiation. You cannot say a product improves outcomes without the evidence to support it, and a reporter on this beat will ask for it. Marketing language that works in software is unusable here.
Patient stories require consent and legal review. The most powerful asset in healthcare communications is a patient willing to describe what happened. Getting one to publication takes weeks and involves people who are not in your marketing meeting.
Regulatory status governs what you can say. Pre-approval, cleared, indicated, off-label — these words have legal meaning. An agency that treats them loosely will get you a warning letter, not coverage.
Medical reporters check things. Health journalism has a strong culture of verifying claims with independent clinicians. Assume anything you assert will be run past somebody who knows the field.
What reply rate should you expect?
Responses to our outreach between December 2025 and August 2026, by company type:
| Company shape | Contacted | Open rate | Response rate |
|---|---|---|---|
| Established name, category past its news cycle | 269 | 54.5% | 11.4% |
| Pre-revenue, launching into a category the press doesn't cover yet | 351 | 54.3% | 10.6% |
| Late stage, recognised founder, crowded category | 700 | 48.3% | 8.5% |
| Market leader in a vertical with specialist trade press | 494 | 47.9% | 8.2% |
Every response, auto-replies included, across the four programmes we could classify this way.
Healthcare typically behaves like the bottom row — a substantial market served by specialist trade press with a thin mainstream beat. Expect 8–11%.
How far the funnel actually gets
Of every 100 pitches delivered, 51 register as opened. That understates it: a tracking pixel only fires if the recipient's client loads remote images. So we work on roughly 7 in 10 rather than 51%. That is our estimate and not a measurement — every blocked pixel is a read nobody counted, which makes the recorded rate a floor. We would rather say where the number comes from than dress it up as measured.
"Our recorded open rate is 51%. The real number is closer to 7 in 10, because a big share of reporters read mail in clients that block tracking pixels. We know it happens because we get replies from people our system says never opened the email. Treat any open rate you're quoted as a floor, including ours."
Justin Mauldin, Founder, Salient PR
Follow-ups do less than you think
| Sequence step | Delivered | Open rate | Reply rate | Replies |
|---|---|---|---|---|
| First email | 2,063 | 47.6% | 6.0% | 124 |
| Follow-up 1 | 1,576 | 37.4% | 3.7% | 59 |
| Follow-up 2 | 69 | 40.6% | 4.3% | 3 |
Two-thirds of every reply came from the first email.
"One follow-up, and it has to add something. If the second email is just 'bumping this up,' you've told them the first one wasn't worth reading either."
Lindsey Ranger, Account Lead, Salient PR
The approval cycle is the real bottleneck
In healthcare this is not a minor operational detail. It determines whether you exist in the news cycle at all.
Pre-clear a quote bank. Three to five approved quotes per spokesperson, covering your standing positions, cleared by legal and regulatory in advance. When a reporter calls at 10am for a 2pm deadline you are editing an approved sentence, not starting a review.
Name one approver with authority. Not a committee. Somebody who can say yes inside four hours.
Agree what does not need review. Funding, headcount, customer counts and product facts already public should not re-enter legal every time.
"The programmes that work are the ones with a standing slot to approve things. When approval is ad hoc, everything ships late and the news peg is gone."
Kristin Kaplan, Operations, Salient PR
"The slowest part of most programmes isn't the agency. It's how long it takes to get a quote approved internally. Companies that can turn a quote in a day get into stories that companies who take a week never see."
Lindsey Ranger, Account Lead, Salient PR
What stories work in healthcare
Aggregate outcome data from your own platform. De-identified, aggregated, and genuinely yours. This is the strongest asset in the category and the one most companies sit on.
A clinician who will speak plainly. Not a chief medical officer reading a statement — somebody who will describe what is actually hard about the problem.
A patient story, done properly. Rare, slow, consent-heavy, and worth more than everything else on this list combined.
Cost and access. Health reporters cover what things cost and who cannot get them far more than they cover technology. A story about access will travel further than a story about your algorithm.
How Salient engages
We ask for a six-month commitment to start, because the first two months are relationship building and judging the work before then tells you nothing. After that there is a 30-day exit, no questions asked, either side. If it is not working we would both rather know.
How to judge a healthcare PR firm
Ask which health reporters they placed in the last six months, by name. Verifiable.
Ask what claims they will stop you making. A firm with real healthcare experience will immediately name three. A generalist will not know there is a problem.
Ask how they work with regulatory and legal. There should be a described process, not an intention.
Ask about embargoes and journal timing. If your news is tied to a publication, the coordination is unforgiving and experience shows.
"Ask for the last 20 pitches they sent in your category and what came back. Not case studies, not a logo wall. The actual sends. If they can't produce that, they aren't measuring, and you'll find out in month four."
Justin Mauldin, Founder, Salient PR
Does AI search change healthcare PR?
More than in most categories, and it raises the stakes on accuracy.
Health queries are among the most heavily summarised by AI systems, and those systems weight source authority heavily. For a healthcare company that means coverage in respected clinical and trade publications now feeds directly into what an AI tells a buyer or a patient about your category.
A peer-reviewed study of generative-engine optimisation (KDD 2024) found that adding direct quotations, statistics and cited sources measurably improved how often a page was surfaced in generative answers — by up to 40% on the authors' benchmark, with the size of the effect varying by subject area. Published, de-identified outcome data with a named clinical author attached is close to the ideal shape for this.
The short version
- Healthcare PR is media relations plus regulated claims plus patient privacy.
- Expect 8–11% reply rates.
- Roughly 7 in 10 actually read it once you adjust for pixel blocking.
- Two-thirds of replies come from the first email.
- The approval cycle, not the agency, decides whether you make deadlines.
- Aggregate outcome data and a plain-speaking clinician beat any product announcement.
Salient PR runs healthcare and health technology PR programmes. All outreach figures come from our own database covering December 2025 to August 2026 and are updated quarterly.
Sources
- Salient PR outreach database, Dec 2025 – Aug 2026
- Aggarwal et al., GEO: Generative Engine Optimization, KDD
If you want this run by people who do it every day — Salient PR is a technology PR agency working with technology companies. See how we work or start a conversation.
Related reading
About Salient PR
Salient is a B2B tech PR agency. We help startups become the story — landing tier-one coverage, building executive visibility, and turning attention into pipeline.
Senior team. No hand-offs. Radical transparency. If you’re ready to talk, reach out.
How healthcare and health tech PR works, why regulatory review is the real bottleneck, and the outreach data behind it, from December 2025 to August 2026.
